Alternatives to Nimbus Therapeutics
Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines. Here are the 54 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Nimbus Therapeutics
Cradle3.0 out of 5 (1)Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Vividion Therapeutics5.0 out of 5 (1)Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.
EvolutionaryScaleNot ratedAI research lab developing frontier models for protein design and biological discovery.
Profluent BioNot ratedAI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Evozyne3.0 out of 5 (1)AI-driven biotech company engineering novel proteins for therapeutics and sustainability.
Ternary TherapeuticsNot ratedAI platform for engineering molecular glues to create a new class of medicines.
Meta-FluxNot ratedAI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
BioNTechNot ratedGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Mammoth BiosciencesNot ratedBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
VizgenNot ratedSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
QuartzyNot ratedA vertically-integrated procurement platform for the life sciences industry.
Showing the next 20 closest matches. See the rest on the Nimbus Therapeutics profile.
Sponsored rows are paid and labelled. Advertise on this page
